Estazolam (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Estazolam" in Italian language version.

refsWebsite

Global rank Italian rank

15nih.gov

4^th place

9^th place

14doi.org

2^nd place

7^th place

12oadoi.org

799^th place

22^nd place

3web.archive.org

1^st place

doi.org

dx.doi.org

T. Akbarzadeh, SA. Tabatabai; MJ. Khoshnoud; B. Shafaghi; A. Shafiee, Design and synthesis of 4H-3-(2-phenoxy)phenyl-1,2,4-triazole derivatives as benzodiazepine receptor agonists., in Bioorg Med Chem, vol. 11, n. 5, marzo 2003, pp. 769-73, DOI:10.1016/S0968-0896(02)00469-8, PMID 12538007.
R Oishi, Nishibori M, Itoh Y, Saeki K., Diazepam-induced decrease in histamine turnover in mouse brain, in Eur J Pharmacol., vol. 124, n. 3, Mag 1986, pp. 337–42, DOI:10.1016/0014-2999(86)90236-0, PMID3089825.
Allen MD, Greenblatt DJ; Arnold JD, Single- and multiple-dose kinetics of estazolam, a triazolo benzodiazepine, in Psychopharmacology (Berl.), vol. 66, n. 3, 1979, pp. 267–74, DOI:10.1007/BF00428318, PMID43552.
Mancinelli A, Guiso G, Garattini S, Urso R, Caccia S, Kinetic and pharmacological studies on estazolam in mice and man, in Xenobiotica, vol. 15, n. 3, marzo 1985, pp. 257–65, DOI:10.3109/00498258509045357, PMID 2862746.
Miura M, Otani K; Ohkubo T;, Identification of human cytochrome P450 enzymes involved in the formation of 4-hydroxyestazolam from estazolam, in Xenobiotica, vol. 35, n. 5, Mag 2005, pp. 455–65, DOI:10.1080/00498250500111612, 16012077.
Raymond C Rosen, Daniel S Lewin, Lawrence Goldberg, Robert L Woolfolk, Psychophysiological insomnia: combined effects of pharmacotherapy and relaxation-based treatments, in Sleep Medicine, vol. 1, n. 4, 2000, pp. 279–288, DOI:10.1016/S1389-9457(00)00042-3, PMID 11040460. URL consultato il 15 dicembre 2013.
Timothy Roehrs, Frank Zorick, Nancy Lord, Gail L. Koshorek, Thomas Roth, Dose-Related Effects of Estazolam on Sleep of Patients with Insomnia, in Journal of Clinical Psychopharmacology, vol. 3, n. 3, 1983, pp. 152–156, DOI:10.1097/00004714-198306000-00002, PMID 6135720. URL consultato il 15 dicembre 2013.
Gary L. Post, Roger O. Patrick, John E. Crowder, John Houston, James M. Ferguson, Robert J. Bielski, Estazolam Treatment of Insomnia in Generalized Anxiety Disorder, in Journal of Clinical Psychopharmacology, vol. 11, n. 4, 1991, pp. 249–253, DOI:10.1097/00004714-199108000-00005. URL consultato il 15 dicembre 2013.
N. Authier, D Balayssac; M Sautereau; A Zangarelli; P Courty; AA Somogyi; B Vennat; PM Llorca; A Eschalier, Benzodiazepine dependence: focus on withdrawal syndrome., in Ann Pharm Fr, vol. 67, n. 6, novembre 2009, pp. 408–13, DOI:10.1016/j.pharma.2009.07.001, PMID19900604.
KT. Bain, Management of chronic insomnia in elderly persons., in Am J Geriatr Pharmacother, vol. 4, n. 2, Giu 2006, pp. 168-92, DOI:10.1016/j.amjopharm.2006.06.006, PMID 16860264.
Lee YJ, Overview of the therapeutic management of insomnia with zolpidem, in CNS Drugs, 18 Suppl 1, 2004, pp. 17–23, DOI:10.2165/00023210-200418001-00005, PMID15291010.
Wang JS, DeVane CL, Pharmacokinetics and drug interactions of the sedative hypnotics (PDF), in Psychopharmacol Bull, vol. 37, n. 1, 2003, pp. 10–29, DOI:10.1007/BF01990373, PMID14561946 (archiviato dall'url originale il 9 luglio 2007).
Miura M, Ohkubo T, Sugawara K, Okuyama N, Otani K, Determination of estazolam in plasma by high-performance liquid chromatography with solid-phase extraction (PDF), in Anal Sci, vol. 18, n. 5, maggio 2002, pp. 525-8, DOI:10.2116/analsci.18.525, PMID 12036118. URL consultato il 15 dicembre 2013 (archiviato dall'url originale il 13 marzo 2020).
Johanson CE, Benzodiazepine self-administration in rhesus monkeys: estazolam, flurazepam and lorazepam, in Pharmacol. Biochem. Behav., vol. 26, n. 3, marzo 1987, pp. 521–6, DOI:10.1016/0091-3057(87)90159-6, 2883668.

nih.gov

ncbi.nlm.nih.gov

C. Braestrup, RF. Squires, Pharmacological characterization of benzodiazepine receptors in the brain., in Eur J Pharmacol, vol. 48, n. 3, aprile 1978, pp. 263-70, PMID 639854.
Estazolam--a new benzodiazepine hypnotic., in Med Lett Drugs Ther, vol. 33, n. 854, Ott 1991, pp. 91-2, PMID 1895992.
T. Akbarzadeh, SA. Tabatabai; MJ. Khoshnoud; B. Shafaghi; A. Shafiee, Design and synthesis of 4H-3-(2-phenoxy)phenyl-1,2,4-triazole derivatives as benzodiazepine receptor agonists., in Bioorg Med Chem, vol. 11, n. 5, marzo 2003, pp. 769-73, DOI:10.1016/S0968-0896(02)00469-8, PMID 12538007.
JB. Hester, AD. Rudzik; BV. Kamdar, 6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines which have central nervous system depressant activity., in J Med Chem, vol. 14, n. 11, novembre 1971, pp. 1078-81, PMID 5165540.
R. Nakajima, C. Hattori; Y. Nagawa, Structure-activity relationship of s-triazolo-1,4-benzodiazepines in central nervous depressant action., in Jpn J Pharmacol, vol. 21, n. 4, Ago 1971, pp. 489-95, PMID 5315779.
Mancinelli A, Guiso G, Garattini S, Urso R, Caccia S, Kinetic and pharmacological studies on estazolam in mice and man, in Xenobiotica, vol. 15, n. 3, marzo 1985, pp. 257–65, DOI:10.3109/00498258509045357, PMID 2862746.
S. Tanayama, Y. Shirakawa; Y. Kanai; Z. Suzuoki, Metabolism of 8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)-benzodiazepine (D-40TA), a new central depressant. I. Absorption, distribution and excretion in rats., in Xenobiotica, vol. 4, n. 1, gennaio 1974, pp. 33-47, PMID 4826814.
Raymond C Rosen, Daniel S Lewin, Lawrence Goldberg, Robert L Woolfolk, Psychophysiological insomnia: combined effects of pharmacotherapy and relaxation-based treatments, in Sleep Medicine, vol. 1, n. 4, 2000, pp. 279–288, DOI:10.1016/S1389-9457(00)00042-3, PMID 11040460. URL consultato il 15 dicembre 2013.
Timothy Roehrs, Frank Zorick, Nancy Lord, Gail L. Koshorek, Thomas Roth, Dose-Related Effects of Estazolam on Sleep of Patients with Insomnia, in Journal of Clinical Psychopharmacology, vol. 3, n. 3, 1983, pp. 152–156, DOI:10.1097/00004714-198306000-00002, PMID 6135720. URL consultato il 15 dicembre 2013.
C. Mauro, P. Sperlongano, Controlled clinical evaluation of 2 hypnotic triazole benzodiazepines, estazolam and triazolam, used the night before surgical interventions, in Minerva Med, vol. 78, n. 18, settembre 1987, pp. 1381-4, PMID 2889169.
KW. Müller, W. Müller-Limmroth; H. Strasser, [Alterations of sleep stage pattern in human beings and hang-over effects under the influence of estazolam/2nd Comm.: Studies on the hang-over effect in psycho-physiological performance (author's transl)]., in Arzneimittelforschung, vol. 32, n. 4, 1982, pp. 456-60, PMID 6125155.
MW. Pierce, VS. Shu; LJ. Groves, Safety of estazolam. The United States clinical experience., in Am J Med, vol. 88, 3A, marzo 1990, pp. 12S-17S, PMID 1968713.
KT. Bain, Management of chronic insomnia in elderly persons., in Am J Geriatr Pharmacother, vol. 4, n. 2, Giu 2006, pp. 168-92, DOI:10.1016/j.amjopharm.2006.06.006, PMID 16860264.
Miura M, Ohkubo T, Sugawara K, Okuyama N, Otani K, Determination of estazolam in plasma by high-performance liquid chromatography with solid-phase extraction (PDF), in Anal Sci, vol. 18, n. 5, maggio 2002, pp. 525-8, DOI:10.2116/analsci.18.525, PMID 12036118. URL consultato il 15 dicembre 2013 (archiviato dall'url originale il 13 marzo 2020).
S. Watanabe, H. Ohta; Y. Sakurai; K. Takao; S. Ueki, [Electroencephalographic effects of 450191-S and its metabolites in rabbits with chronic electrode implants]., in Nihon Yakurigaku Zasshi, vol. 88, n. 1, Lug 1986, pp. 19-32, PMID 3758874.

oadoi.org

T. Akbarzadeh, SA. Tabatabai; MJ. Khoshnoud; B. Shafaghi; A. Shafiee, Design and synthesis of 4H-3-(2-phenoxy)phenyl-1,2,4-triazole derivatives as benzodiazepine receptor agonists., in Bioorg Med Chem, vol. 11, n. 5, marzo 2003, pp. 769-73, DOI:10.1016/S0968-0896(02)00469-8, PMID 12538007.
R Oishi, Nishibori M, Itoh Y, Saeki K., Diazepam-induced decrease in histamine turnover in mouse brain, in Eur J Pharmacol., vol. 124, n. 3, Mag 1986, pp. 337–42, DOI:10.1016/0014-2999(86)90236-0, PMID3089825.
Allen MD, Greenblatt DJ; Arnold JD, Single- and multiple-dose kinetics of estazolam, a triazolo benzodiazepine, in Psychopharmacology (Berl.), vol. 66, n. 3, 1979, pp. 267–74, DOI:10.1007/BF00428318, PMID43552.
Mancinelli A, Guiso G, Garattini S, Urso R, Caccia S, Kinetic and pharmacological studies on estazolam in mice and man, in Xenobiotica, vol. 15, n. 3, marzo 1985, pp. 257–65, DOI:10.3109/00498258509045357, PMID 2862746.
Miura M, Otani K; Ohkubo T;, Identification of human cytochrome P450 enzymes involved in the formation of 4-hydroxyestazolam from estazolam, in Xenobiotica, vol. 35, n. 5, Mag 2005, pp. 455–65, DOI:10.1080/00498250500111612, 16012077.
Raymond C Rosen, Daniel S Lewin, Lawrence Goldberg, Robert L Woolfolk, Psychophysiological insomnia: combined effects of pharmacotherapy and relaxation-based treatments, in Sleep Medicine, vol. 1, n. 4, 2000, pp. 279–288, DOI:10.1016/S1389-9457(00)00042-3, PMID 11040460. URL consultato il 15 dicembre 2013.
Timothy Roehrs, Frank Zorick, Nancy Lord, Gail L. Koshorek, Thomas Roth, Dose-Related Effects of Estazolam on Sleep of Patients with Insomnia, in Journal of Clinical Psychopharmacology, vol. 3, n. 3, 1983, pp. 152–156, DOI:10.1097/00004714-198306000-00002, PMID 6135720. URL consultato il 15 dicembre 2013.
Gary L. Post, Roger O. Patrick, John E. Crowder, John Houston, James M. Ferguson, Robert J. Bielski, Estazolam Treatment of Insomnia in Generalized Anxiety Disorder, in Journal of Clinical Psychopharmacology, vol. 11, n. 4, 1991, pp. 249–253, DOI:10.1097/00004714-199108000-00005. URL consultato il 15 dicembre 2013.
N. Authier, D Balayssac; M Sautereau; A Zangarelli; P Courty; AA Somogyi; B Vennat; PM Llorca; A Eschalier, Benzodiazepine dependence: focus on withdrawal syndrome., in Ann Pharm Fr, vol. 67, n. 6, novembre 2009, pp. 408–13, DOI:10.1016/j.pharma.2009.07.001, PMID19900604.
KT. Bain, Management of chronic insomnia in elderly persons., in Am J Geriatr Pharmacother, vol. 4, n. 2, Giu 2006, pp. 168-92, DOI:10.1016/j.amjopharm.2006.06.006, PMID 16860264.
Lee YJ, Overview of the therapeutic management of insomnia with zolpidem, in CNS Drugs, 18 Suppl 1, 2004, pp. 17–23, DOI:10.2165/00023210-200418001-00005, PMID15291010.
Johanson CE, Benzodiazepine self-administration in rhesus monkeys: estazolam, flurazepam and lorazepam, in Pharmacol. Biochem. Behav., vol. 26, n. 3, marzo 1987, pp. 521–6, DOI:10.1016/0091-3057(87)90159-6, 2883668.

web.archive.org

Wang JS, DeVane CL, Pharmacokinetics and drug interactions of the sedative hypnotics (PDF), in Psychopharmacol Bull, vol. 37, n. 1, 2003, pp. 10–29, DOI:10.1007/BF01990373, PMID14561946 (archiviato dall'url originale il 9 luglio 2007).
Miura M, Ohkubo T, Sugawara K, Okuyama N, Otani K, Determination of estazolam in plasma by high-performance liquid chromatography with solid-phase extraction (PDF), in Anal Sci, vol. 18, n. 5, maggio 2002, pp. 525-8, DOI:10.2116/analsci.18.525, PMID 12036118. URL consultato il 15 dicembre 2013 (archiviato dall'url originale il 13 marzo 2020).
(EN) Food and Drug Administration, FDA Warns consumers against taking dietary supplement "Sleeping Buddha", su fda.gov, U.S. Department of Health and Human Services, 10 marzo 1998. URL consultato il 21 dicembre 2008 (archiviato dall'url originale il 12 aprile 2007).